IgM myeloma: A multicenter retrospective study of 134 patients
Jorge J. Castillo(Miriam Hospital), Morie A. Gertz(Mayo Clinic in Arizona), Luděk Pour(University Hospital Brno), David Jayabalan(Cornell University), Elisabet E. Manasanch(National Institutes of Health), Elizabeth A. Morgan(Otsuka (Japan)), Mark A. Fiala, Marion Eveillard(Nantes Université), Irene M. Ghobrial(Harvard University), Anna Waszczuk‐Gajda(Medical University of Warsaw), Ravi Vij(Washington University in St. Louis), Ivan Špıčka(Charles University), Alessandro Gozzetti(University of Siena), Paul G. Richardson(Dana-Farber Cancer Institute), Artur Jurczyszyn(Jagiellonian University), Jiří Jarkovský(Masaryk University), Hareth Nahi(Karolinska University Hospital), Jacob P. Laubach(Harvard University), Julio Dávila(Universidad de Salamanca), John L. Reagan(Vanderbilt University), Joshua Gustine(Harvard University), Edvan de Queiroz Crusoé(Complexo Hospitalar Universitário Professor Edgard Santos), Lucie Brožová(Masaryk University), Rubén Niesvizky(Cornell University), Jacek Czepiel(Jagiellonian University), Vladimír Maisnar(Charles University), Barbara Lewicka(Jagiellonian University), Claudia E. Paba‐Prada(Harvard University), Roman Hájek(University Hospital Brno), Philippe Moreau(Institut Paoli-Calmettes), Vânia Hungria(São Germano Oncologia), Angela Dispenzieri(WinnMed), Jatin J. Shah(The University of Texas MD Anderson Cancer Center), Tomáš Pika(University Hospital Olomouc)
Cited by 49
Related Papers
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k